0 Comments
0 Shares
1K Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Lung Cancer Liquid Biopsy Market – Industry Trends and Forecast to 2030Regional Overview of Executive Summary Lung Cancer Liquid Biopsy Market by Size and Share CAGR Value Data Bridge Market Research analyses that the lung cancer liquid biopsy market which was USD 0.30 billion in 2022, is expected to reach USD 1.38 billion by 2030, at a CAGR of 21% during the forecast period 2023 to 2030. The market report also contains the drivers and restraints...0 Comments 0 Shares 192 Views 0 Reviews
-
Biopsy Devices Market: How Are Liquid Biopsy Devices Creating a New Diagnostic Market?Liquid biopsy — the analysis of circulating tumor DNA, circulating tumor cells, exosomes, and other cancer-derived materials in blood samples providing cancer detection, characterization, and monitoring without tissue biopsy — represents the most commercially disruptive innovation in the biopsy devices market, with the Biopsy Devices Market reflecting liquid biopsy as a rapidly...0 Comments 0 Shares 252 Views 0 Reviews
-
Exosome Therapeutics Market: How Are Exosome Diagnostics Advancing Liquid Biopsy?Engineered exosomes — the genetically or chemically modified exosomes with enhanced targeting, improved cargo loading, or augmented therapeutic properties beyond naturally derived exosomes — represent the next technological evolution addressing the limitations of native exosome therapeutics, with the Exosome Therapeutics Market reflecting engineered exosomes as the primary...0 Comments 0 Shares 202 Views 0 Reviews
-
Extracellular-Vesicles-Based-Liquid-Biopsy-Market Size, Share, Trends & Forecast Report 2026–2032Global Demand Outlook for Executive Summary Extracellular Vesicles Based Liquid Biopsy Market Size and Share The global extracellular vesicles based liquid biopsy market size was valued at USD 115.09 Million in 2024 and is expected to reach USD 539.41 Million by 2032, at a CAGR of 21.3% during the forecast period In order to make smart decisions about...0 Comments 0 Shares 20 Views 0 Reviews
-
Liquid Biopsy Market Transforming Cancer Diagnostics and Precision MedicineThe liquid biopsy market is rapidly redefining how cancer is detected, monitored, and treated. Unlike traditional tissue biopsies, liquid biopsy relies on a simple blood sample to identify tumor-derived components such as circulating tumor DNA (ctDNA), RNA, and exosomes. This non-invasive approach is emerging as a cornerstone of precision medicine, enabling clinicians to make...0 Comments 0 Shares 26 Views 0 Reviews
-
North America Ovarian Cancer Diagnostics Market: Liquid Biopsy Trends and Strategic Forecast 2032"Executive Summary North America Ovarian Cancer Diagnostics Market Size and Share Across Top Segments North America ovarian cancer diagnostics market is expected to grow in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.8% in the forecast period of 2023 to 2030 and is expected to reach USD 5,675.36 million by 2030...0 Comments 0 Shares 1K Views 0 Reviews
-
Precision Medicine Market: How Is Liquid Biopsy Advancing Precision Oncology?Liquid biopsy — the analysis of circulating tumor DNA, circulating tumor cells, exosomes, and other cancer-derived materials in blood to detect, characterize, and monitor cancer non-invasively — represents a transformative precision oncology diagnostic approach, with the Precision Medicine Market reflecting liquid biopsy as one of the most commercially significant precision...0 Comments 0 Shares 297 Views 0 Reviews
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek